Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Total Current Liabilities (2011 - 2026)

Palatin Technologies' (PTN) quarterly Total Current Liabilities came in at $2.5 million in Q1 2026, down 74.76% on a YoY basis from $10.0 million in Q1 2025, and down 59.95% quarter-over-quarter from $6.3 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Total Current Liabilities (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Total Current Liabilities for 15 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 74.76% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 74.76% YoY), and the FY2025 full-year result was $8.0 million, down 17.06% from the prior year.
  • Total Current Liabilities eased to $2.5 million in Q1 2026 per PTN's latest filing, from $6.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $16.3 million in Q2 2022 and bottomed at $2.5 million in Q1 2026.
  • Historically, Total Current Liabilities has averaged $10.6 million across 5 years, with a median of $10.0 million in 2025.
  • The sharpest annual moves came in 2022 and 2026: Total Current Liabilities soared 62.05% in 2022, then tumbled 74.76% in 2026.
  • Over 5 years, Total Current Liabilities stood at $11.4 million in 2022, then fell by 1.93% to $11.2 million in 2023, then retreated by 14.65% to $9.6 million in 2024, then sank by 33.75% to $6.3 million in 2025, then slumped by 59.95% to $2.5 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $2.5 million, $6.3 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 283.60 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 2.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.54 Mn
Dec 31, 2025 6.33 Mn
Sep 30, 2025 8.22 Mn
Jun 30, 2025 8.01 Mn
Mar 31, 2025 10.05 Mn
Dec 31, 2024 9.56 Mn
Sep 30, 2024 9.86 Mn
Jun 30, 2024 9.66 Mn
Mar 31, 2024 8.53 Mn
Dec 31, 2023 11.20 Mn
Sep 30, 2023 13.61 Mn
Jun 30, 2023 15.13 Mn
Mar 31, 2023 11.85 Mn
Dec 31, 2022 11.42 Mn
Sep 30, 2022 15.86 Mn
Jun 30, 2022 16.26 Mn
Mar 31, 2022 11.98 Mn
Dec 31, 2021 13.86 Mn
Sep 30, 2021 9.79 Mn
Jun 30, 2021 10.51 Mn